K972963 is an FDA 510(k) clearance for the MODIFIED CEDIA DAU PCP ASSAY. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Boehringer Mannheim Corp. (Concord, US). The FDA issued a Cleared decision on September 22, 1997 after a review of 42 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Boehringer Mannheim Corp. devices